Entry Point Capital, LLC Essa Pharma Inc. Transaction History
Entry Point Capital, LLC
- $112 Billion
- Q1 2024
A detailed history of Entry Point Capital, LLC transactions in Essa Pharma Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 4,420 shares of EPIX stock, worth $22,586. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,420Holding current value
$22,586% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding EPIX
# of Institutions
36Shares Held
35MCall Options Held
53.4KPut Options Held
29.4K-
Bvf Inc San Francisco, CA8.75MShares$44.7 Million2.22% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.89MShares$40.3 Million1.05% of portfolio
-
Morgan Stanley New York, NY4.18MShares$21.4 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.59MShares$18.3 Million2.49% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.98MShares$15.2 Million1.25% of portfolio
About ESSA Pharma Inc.
- Ticker EPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,073,100
- Market Cap $225M
- Description
- ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...